In today’s briefing:
- Austar Lifesciences (6118 HK): It’s Risky to Catch the Falling Knife
Austar Lifesciences (6118 HK): It’s Risky to Catch the Falling Knife
- Management is not aware of any significant reason for the recent unusual price movement in Austar Lifesciences (6118 HK) shares.
- The company’s strong financial performance in H1 2021 and order book seems to be mostly driven by the COVID-19 vaccine-related demand, which is expected to fade off this year.
- Divestment of its 60% equity interest in Pall-Austar Lifesciences is expected to weaken its competitive positioning in the lifescience tool market in China.
Before it’s here, it’s on Smartkarma
